Medical linear accelerators and related products

LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumorsForm:SolidIC50&amp: Target:TLR7.

LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumorsForm:SolidIC50&amp: Target:TLR7.

InformationTezacaftor (VX-661) Tezacaftor (VX-661) is a second F508del CFTR corrector and is believed to help CFTR protein reach the cell surface. Phase 2.In vitroVX-661, known as a CTFR corrector, allows F508del mutant channels to escape

Obatoclax (GX15-070).

Obatoclax (GX15-070).

Obatoclax (GX15-070).

Obatoclax (GX15-070).

Obatoclax (GX15-070).

InformationCabazitaxel (XRP6258) Cabazitaxel (RPR-116258A, XRP6258, TXD 258, Taxoid XRP6258) is a semi-synthetic derivative of a natural taxoid that kills cancer cells by inhibiting cell division and growth. Cabazitaxel exerts its effects by

InformationC75 trans C75 trans (trans-C75, (±)-C75) is a novel, potent synthetic inhibitor of fatty acid synthase (FAS/FASN) with IC50 of 35 μM and 50 μM in clonogenic assays and spheroid growth assay, respectively. C75 is used as a tool for

Potent and selective ERK5 inhibitor.

Potent and selective ERK5 inhibitor.